Cytopathology

Ebola breakthrough

Ebola could soon be “preventable and treatable”, after a trial of two drugs showed significantly improved survival rates.

Targeting the spread of pancreatic cancer

An international team of scientists has revealed how aggressive pancreatic cancer cells change their environment to enable metastasis – the main cause of pancreatic cancer-related death.

Urine test for prostate cancer

Scientists have developed a urine test to diagnose aggressive prostate cancer and predict whether patients will require treatment up to five years earlier than standard clinical methods.

Flow cytometry challenges

Clinical Scientist Helen Watson explains the challenges faced working in a leading haematopoietic stem cell transplantation centre.

High hopes for pioneering CAR-T

NHS patients with lymphoma have been given a pioneering treatment that genetically reprogrammes their immune system to fight cancer.

Head and neck cancers

Vaccinating schoolboys against the potentially deadly human papillomavirus (HPV) could dramatically reduce head and neck cancers in men, it is claimed.

Self-destructing cancer cells

Constantinos Koumenis says his new target for cancer may be an important step in progress, but stresses that there is no magic bullet to stop the disease.

Q&A Professor Robert Langer

Professor Robert Langer, Institute Professor at the Massachusetts Institute of Technology (MIT) and a scientist, entrepreneur and inventor, discusses his research, advances in cancer treatment, biomaterials and slow-release medicines.

May journal-based learning exercises

Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

War on cancer pt.2: landmarks in the development of chemotherapy

The second article of two, which briefly reviews the historical developments and use of chemotherapy since 1948 to treat different cancers. 
 

April: News in numbers

A breakdown of science news this month, in numbers.

Top